Clorox Slips As Wells Fargo Says Sell, Calls 'Dead Money At Best'

Credit Suisse analyst Kaumil Gajrawala also lowered his price target on Clorox to $185 from $205 but kept a Neutral rating on the shares. The analyst highlighted that Clorox reported organic sales down 1% in the third quarter versus expectations of up 5%. Lower shipments of cleaning and disinfecting products, as well as supply constraints on wipes, drove the miss, Gajrawala added, pointing out that limited mobility is still a drag on Burt's Bees, but driving at-home consumption of charcoal, cat litter, and trash bags.

Meanwhile, Deutsche Bank analyst Steve Powers lowered the firm's price target on Clorox to $186 from $195, keeping a Hold rating on the shares. The company reported a "disappointing" quarter Friday in terms of the top-line results, owing to weaker sales in its Health and Wellness segment, Powers told investors in a research note of his own.


In afternoon trading, shares of Clorox dropped about 1% to $181.16.

1 2
View single page >> |

Disclaimer: TheFly's news is intended for informational purposes only and does not claim to be actionable for investment decisions. Read more at  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.